<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03689101</url>
  </required_header>
  <id_info>
    <org_study_id>P2018009</org_study_id>
    <nct_id>NCT03689101</nct_id>
  </id_info>
  <brief_title>The Relationship Between CD138 Count of Endometrium and Reproductive Outcome</brief_title>
  <official_title>To Explore the Relationship Between Endometrial CD138 Count and Pregnancy Outcome Following Frozen Embryo Transfer in Natural Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's well known, endometritis affects reproductive outcomes. Though CD138 counting as one new
      diagnosis measure for endometritis, diagnostic criterion of this measure isn't consistent.
      And if the CD138 counting is correlation to the outcome of reproductive is not clear.

      Firstly, This study aims to explore the relationship between endometrial CD138 count and
      pregnancy outcome following frozen embryo transfer in natural cycles. Secondly , the
      investigators want to find a cut-off value which is related to reproduction outcome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2016</start_date>
  <completion_date type="Actual">February 2, 2019</completion_date>
  <primary_completion_date type="Actual">November 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CD138 counting</measure>
    <time_frame>7 days after LH surge (LH+7)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>about 28 days after embryo transfer</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Endometrial biopsies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endometrial biopsy was performed precisely 7 days after LH surge (LH+7) to count endometrial CD138.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endometrial biopsies</intervention_name>
    <description>Endometrial biopsy was performed precisely 7 days after LH surge (LH+7)</description>
    <arm_group_label>Endometrial biopsies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between20 and 38 years;

          -  regular menstrual cycles;

          -  body mass index (BMI) ranged from 18 to 25

        Exclusion Criteria:

          -  uterine abnormalities;

          -  intrauterine adhesions（moderate - severe）, advanced endometriosis, adenomyosis,
             untreated hydrosalpinx, uterine fibroids (submucosal fibroids, nonmucosal fibroids
             &gt;4.0 cm and/or endometrial pressure)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fei Gong, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-XIANGYA</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2018</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

